| Dr Shannon L Mccarthy, DO | |
|
1800 W. Charleston Blvd., Las Vegas, NV 89102 | |
| (702) 383-2000 | |
| (702) 383-3875 |
| Full Name | Dr Shannon L Mccarthy |
|---|---|
| Gender | Female |
| Speciality | Infectious Disease |
| Experience | 12 Years |
| Location | 1800 W. Charleston Blvd., Las Vegas, Nevada |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902169659 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 0102203723 (Virginia) | Secondary |
| 207RI0200X | Internal Medicine - Infectious Disease | DO2854 (Nevada) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Medical Center | Las vegas, NV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Medical Center Of Southern Nevada | 7315934429 | 243 |
News Archive
Stopping bacteria from talking to each other could help prevent serious infections say scientists from Aberdeen, in new research presented Monday at the Society for General Microbiology's 155th Meeting at Trinity College Dublin.
Neovasc Inc., a developer of novel technologies used to treat vascular disease, today presented results from the follow-up phase of the initial clinical trial of its Neovasc Reducer(TM) product at the American College of Cardiology 2010 annual meeting. The Neovasc Reducer is a novel implantable product designed to treat heart disease patients who suffer from refractory angina. The new data shows that three years after implantation of the Reducer, the majority of patients continued to show measurable improvement in angina symptoms.
Chicago Facial Plastic Surgeon, Steven H. Dayan, MD, FACS, publishes a study in the November 2010 issue of Dermatologic Surgery, a prominent Dermatology journal, demonstrating that increases in overall quality of life and self-esteem were observed in participants treated with Botulinum Toxin Type A or Botox Cosmetic. In this double-blind randomized placebo-controlled survey, Dr. Dayan and DeNova research worked with one hundred participants who were treated with either Botox Cosmetic or a saline placebo for facial wrinkles.
Decision Resources Group finds the number of US consumers that are using their smartphones and tablets to search for prescription drug information is rising rapidly, according to data from ePharma Consumer 2013, while searches through desktops and laptops is beginning to wane, reinforcing the need for prescription drug marketers to prioritize mobile investments.
› Verified 1 days ago
| Entity Name | University Medical Center Of Southern Nevada |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548393127 PECOS PAC ID: 7315934429 Enrollment ID: O20040429001053 |
News Archive
Stopping bacteria from talking to each other could help prevent serious infections say scientists from Aberdeen, in new research presented Monday at the Society for General Microbiology's 155th Meeting at Trinity College Dublin.
Neovasc Inc., a developer of novel technologies used to treat vascular disease, today presented results from the follow-up phase of the initial clinical trial of its Neovasc Reducer(TM) product at the American College of Cardiology 2010 annual meeting. The Neovasc Reducer is a novel implantable product designed to treat heart disease patients who suffer from refractory angina. The new data shows that three years after implantation of the Reducer, the majority of patients continued to show measurable improvement in angina symptoms.
Chicago Facial Plastic Surgeon, Steven H. Dayan, MD, FACS, publishes a study in the November 2010 issue of Dermatologic Surgery, a prominent Dermatology journal, demonstrating that increases in overall quality of life and self-esteem were observed in participants treated with Botulinum Toxin Type A or Botox Cosmetic. In this double-blind randomized placebo-controlled survey, Dr. Dayan and DeNova research worked with one hundred participants who were treated with either Botox Cosmetic or a saline placebo for facial wrinkles.
Decision Resources Group finds the number of US consumers that are using their smartphones and tablets to search for prescription drug information is rising rapidly, according to data from ePharma Consumer 2013, while searches through desktops and laptops is beginning to wane, reinforcing the need for prescription drug marketers to prioritize mobile investments.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Shannon L Mccarthy, DO 1800 W. Charleston Blvd., Las Vegas, NV 89102 Ph: (702) 383-2000 | Dr Shannon L Mccarthy, DO 1800 W. Charleston Blvd., Las Vegas, NV 89102 Ph: (702) 383-2000 |
News Archive
Stopping bacteria from talking to each other could help prevent serious infections say scientists from Aberdeen, in new research presented Monday at the Society for General Microbiology's 155th Meeting at Trinity College Dublin.
Neovasc Inc., a developer of novel technologies used to treat vascular disease, today presented results from the follow-up phase of the initial clinical trial of its Neovasc Reducer(TM) product at the American College of Cardiology 2010 annual meeting. The Neovasc Reducer is a novel implantable product designed to treat heart disease patients who suffer from refractory angina. The new data shows that three years after implantation of the Reducer, the majority of patients continued to show measurable improvement in angina symptoms.
Chicago Facial Plastic Surgeon, Steven H. Dayan, MD, FACS, publishes a study in the November 2010 issue of Dermatologic Surgery, a prominent Dermatology journal, demonstrating that increases in overall quality of life and self-esteem were observed in participants treated with Botulinum Toxin Type A or Botox Cosmetic. In this double-blind randomized placebo-controlled survey, Dr. Dayan and DeNova research worked with one hundred participants who were treated with either Botox Cosmetic or a saline placebo for facial wrinkles.
Decision Resources Group finds the number of US consumers that are using their smartphones and tablets to search for prescription drug information is rising rapidly, according to data from ePharma Consumer 2013, while searches through desktops and laptops is beginning to wane, reinforcing the need for prescription drug marketers to prioritize mobile investments.
› Verified 1 days ago
Dr. Arshi A. Quadeer, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2545 S Bruce St Ste 200, Las Vegas, NV 89169 Phone: 702-732-2438 Fax: 702-737-5043 | |
Cherie Lin, D.O. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 3006 S Maryland Pkwy, Suite 400, Las Vegas, NV 89109 Phone: 702-369-5582 Fax: 702-369-1533 | |
Michael M Lee, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 1800 W Charleston Blvd, Las Vegas, NV 89102 Phone: 702-921-6823 Fax: 702-549-5240 | |
Henry Palangdao Igid, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 653 N Town Center Dr Ste 402, Las Vegas, NV 89144 Phone: 702-243-7200 Fax: 702-243-7235 | |
Ian Adrian Fanoga Frani, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1800 W Charleston Blvd, Las Vegas, NV 89102 Phone: 702-383-2000 Fax: 702-383-3875 | |
Sein Tun, DO Infectious Disease Medicare: Medicare Enrolled Practice Location: 620 Shadow Ln, Las Vegas, NV 89106 Phone: 702-388-4000 | |
Berge Jack Dadourian, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 400 S Rampart Blvd, Suite 240, Las Vegas, NV 89145 Phone: 702-906-1100 Fax: 702-906-1110 |